Health
Convalescent plasma fails to improve outcome of COVID-19 in India – News-Medical.Net
A new study based in India and published on the medRxiv preprint server explores the role of convalescent plasma (CP) in the treatment of moderate COVID-19 within the limitations on resources faced in a developing country.
The COVID-19 pandemic is still raging in India, with over 4.37 million cases and almost 90,000 new cases a day at present. There are few effective therapeutic options, which means that healthcare providers are faced with ongoing challenges in managing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A new study based in India and published on the medRxiv* preprint server explores the role of convalescent plasma (CP) in the treatment of moderate COVID-19 within the limitations on…
Continue Reading
